UroGen Pharma Market Cap

UroGen Pharma has a market cap or net worth of 508.91 million as of June 20, 2025. Its market cap has increased by 37.20% in one year.

Market Cap

508.91M

Enterprise Value

453.95M

Revenue

71.11M

Ranking

n/a

PE Ratio

n/a

Stock Price

14.85

Market Cap Chart

Since May 4, 2017, UroGen Pharma's market cap has increased from 129.71M to 508.91M, an increase of 292.35%. That is a compound annual growth rate of 18.31%.

Market Cap History

Date	Market Cap	% Change
Jun 18, 2025	508.91M	41.76%
Dec 31, 2024	358.99M	-1.24%
Dec 29, 2023	363.49M	113.84%
Dec 30, 2022	169.98M	7.95%
Dec 31, 2021	157.47M	-46.00%
Dec 31, 2020	291.60M	-44.84%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	163.63B
Shell	159.81B
HSBC Holdings	149.96B
Unilever	114.03B
British American Tobacco p.l.c.	79.95B
Rolls-Royce Holdings	73.74B
RELX PLC	71.63B
Rio Tinto Group	70.34B

Market Cap Rankings